These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14667570)

  • 1. Hyperphosphatemia in multiple myeloma.
    Cheikhrouhou Abdelmoula L; Amira C; Chaabouni L; Kchir MM; Zouari R
    Joint Bone Spine; 2003 Dec; 70(6):541-2. PubMed ID: 14667570
    [No Abstract]   [Full Text] [Related]  

  • 2. Make your diagnosis. Multiple myeloma-associated with spurious hyperphosphatemia.
    Izzedine H; Camous L; Bourry E; Azar N; Leblond V; Deray G
    Kidney Int; 2007 Oct; 72(8):1035-6. PubMed ID: 17914422
    [No Abstract]   [Full Text] [Related]  

  • 3. How should hyperphosphatemia be managed in dialysis patients?
    Block G; Uribarri J; Coladonato JA; Fan SL; Cunningham J; Nolan CR; Qunibi WY; Lindberg JS
    Semin Dial; 2002; 15(5):315-28. PubMed ID: 12358631
    [No Abstract]   [Full Text] [Related]  

  • 4. Pleiotropic effects of the non-calcium phosphate binder sevelamer.
    Nikolov IG; Joki N; Maizel J; Lacour B; Drüeke TB; Massy ZA
    Kidney Int Suppl; 2006 Dec; (105):S16-23. PubMed ID: 17136111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amyloidosis associated with multiple myeloma].
    Hirota K; Furusawa S
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):480-3. PubMed ID: 9851195
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease.
    Cozzolino M; Brancaccio D
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):341-3. PubMed ID: 17874964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effect of introduction of sevelamer hydrochloride in patients with hyperphosphatemia undergoing maintenance dialysis].
    Tahara H; Tsujimoto Y; Shouji T; Inaba M; Tabata T; Nishizawa Y
    Clin Calcium; 2005 Sep; 15 Suppl 1():173-9. PubMed ID: 16279021
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in the management of hyperphosphatemia in chronic kidney disease.
    McIntyre CW
    Semin Dial; 2007; 20(4):337-41. PubMed ID: 17635825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary myelodysplastic syndrome in patients with multiple myeloma].
    Abdulkadyrov KM; Gritsaev SV; Bessmel'tsev SS; Martynkevich IS; Tiranova SA; Blinov MN; Stel'mashenko LV; Pesterova VV
    Ter Arkh; 2004; 76(7):85-7. PubMed ID: 15379135
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukoencephalopathy in multiple myeloma: two case reports.
    Lebrun C; Chanalet S; Frenay M; Chatel M
    Ann Oncol; 1999 Dec; 10(12):1515-7. PubMed ID: 10643546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for hyperphosphatemia.
    Bellinghieri G; Santoro D; Savica V
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):355-65. PubMed ID: 17874966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lanthanum carbonate--new data on parathyroid hormone control without liver damage.
    Cozzolino M; Brancaccio D
    Nephrol Dial Transplant; 2007 Feb; 22(2):316-8. PubMed ID: 17151005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hyperphosphatemia in dialyzed patients with nicotinamide].
    Galeano C; Navarro P; Teruel JL; Ortuño J
    Nefrologia; 2005; 25(6):725-6. PubMed ID: 16514919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phosphoremia and phosphate ion in medico-surgical resuscitation. Variations and therapeutic approach].
    Eydan R; Nicolas Y; Chaspoul C; Lemoine P; Bon R; Jezequel R; Gotty M
    Anesth Analg (Paris); 1974; 31(4):595-605. PubMed ID: 4440898
    [No Abstract]   [Full Text] [Related]  

  • 15. [1,25-(OH)2-D3 treatment of hypophosphoremic osteomalacia associated with villonodular synovitis].
    Dougados M; Amor B; Medicis P; Ulmann A
    Ann Med Interne (Paris); 1984; 135(4):269-73. PubMed ID: 6548101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of calcium and phosphorus metabolism in rheumatoid arthritis].
    Ota K; Uezu A
    Nihon Rinsho; 1982; 40(12):2729-37. PubMed ID: 6761466
    [No Abstract]   [Full Text] [Related]  

  • 17. [Spurious hyperphosphatemia in multiple myeloma].
    Jarchovsky I; Beitner H; Plavnick L
    Harefuah; 1991 Dec; 121(12):515-6. PubMed ID: 1794758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deviations of calcium and phosphorus metabolism in hematologic diseases].
    Takaku F
    Nihon Rinsho; 1982; 40(12):2745-50. PubMed ID: 6761468
    [No Abstract]   [Full Text] [Related]  

  • 19. Spuriously high phosphate level which is promptly resolved after plasmapheresis in a patient with multiple myeloma.
    Kiki I; Gundogdu M; Kaya H
    Transfus Apher Sci; 2007 Oct; 37(2):157-9. PubMed ID: 18037346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudohyperphosphatemia in multiple myeloma.
    El Bouchti I; Belkhou A; Younsi R; El Asan S
    Joint Bone Spine; 2007 Mar; 74(2):206-7. PubMed ID: 17337230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.